Insider Transactions in Q2 2021 at Verona Pharma PLC (VRNA)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 04
2021
|
Mahendra Shah Director |
SELL
Open market or private sale
|
Direct |
10,680
-12.75%
|
$0
$0.84 P/Share
|
|
May 04
2021
|
Martin Edwards Director |
SELL
Open market or private sale
|
Direct |
12,024
-9.77%
|
$0
$0.84 P/Share
|
|
May 04
2021
|
David R Ebsworth Director |
SELL
Open market or private sale
|
Direct |
11,184
-1.61%
|
$0
$0.84 P/Share
|
|
May 04
2021
|
Vikas Sinha Director |
SELL
Open market or private sale
|
Direct |
10,016
-11.86%
|
$0
$0.84 P/Share
|
|
May 04
2021
|
Kenneth Cunningham Director |
SELL
Open market or private sale
|
Direct |
13,112
-16.45%
|
$0
$0.84 P/Share
|
|
May 04
2021
|
Lisa Deschamps Director |
SELL
Open market or private sale
|
Direct |
10,680
-9.21%
|
$0
$0.84 P/Share
|
|
May 04
2021
|
Anders Ullman Director |
SELL
Open market or private sale
|
Direct |
12,056
-3.48%
|
$0
$0.84 P/Share
|
|
May 04
2021
|
David Zaccardelli President and CEO |
SELL
Open market or private sale
|
Direct |
52,056
-0.29%
|
$0
$0.81 P/Share
|
|
May 03
2021
|
Mark W Hahn Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
10,416
-0.06%
|
$0
$0.87 P/Share
|
|
May 03
2021
|
Mark W Hahn Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,122,448
-11.14%
|
$0
$0.89 P/Share
|
|
May 03
2021
|
David Zaccardelli President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,139,632
-10.67%
|
$0
$0.89 P/Share
|